Dr Reddy's Laboratories SG&A Expenses 2010-2024 | RDY

Dr Reddy's Laboratories sg&a expenses for the twelve months ending September 30, 2024 were $1.030B, a 18.72% increase year-over-year.

  • Dr Reddy's Laboratories annual sg&a expenses for 2024 were $0.926B, a 11.84% increase from 2023.
  • Dr Reddy's Laboratories annual sg&a expenses for 2023 were $0.828B, a 1.22% increase from 2022.
  • Dr Reddy's Laboratories annual sg&a expenses for 2022 were $0.818B, a 9.5% increase from 2021.

Dr Reddy's Laboratories SG&A Expenses 2010-2024 | RDY

  • Dr Reddy's Laboratories annual sg&a expenses for 2024 were $0.926B, a 11.84% increase from 2023.
  • Dr Reddy's Laboratories annual sg&a expenses for 2023 were $0.828B, a 1.22% increase from 2022.
  • Dr Reddy's Laboratories annual sg&a expenses for 2022 were $0.818B, a 9.5% increase from 2021.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
BridgeBio Pharma (BBIO)$4.4B
Bausch Health Cos (BHC)$2.9B
Amphastar Pharmaceuticals (AMPH)$2.2B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$506M
Personalis (PSNL)$245M
Assembly Biosciences (ASMB)$96M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$6M
Teligent (TLGT)$0M